pimecrolimus is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Pimecrolimus.
Product ID | 0591-2944_a3f0bc92-796c-4f74-8c7a-63001b4e9e43 |
NDC | 0591-2944 |
Product Type | Human Prescription Drug |
Proprietary Name | pimecrolimus |
Generic Name | Pimecrolimus |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2018-12-27 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA209345 |
Labeler Name | Actavis Pharma, Inc. |
Substance Name | PIMECROLIMUS |
Active Ingredient Strength | 10 mg/g |
Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-12-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA209345 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-12-27 |
Marketing Category | ANDA |
Application Number | ANDA209345 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-12-27 |
Marketing Category | ANDA |
Application Number | ANDA209345 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2018-12-27 |
Ingredient | Strength |
---|---|
PIMECROLIMUS | 10 mg/g |
SPL SET ID: | d5b0403a-065f-42e3-96d6-7dcb9ab127d3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0591-2944 | pimecrolimus | pimecrolimus |
68462-609 | Pimecrolimus | Pimecrolimus |
68682-110 | Pimecrolimus | Pimecrolimus |
68682-111 | Pimecrolimus | Pimecrolimus |
68682-112 | Pimecrolimus | Pimecrolimus |
70518-2292 | pimecrolimus | pimecrolimus |
0187-5100 | ELIDEL | Pimecrolimus |
0187-5101 | ELIDEL | Pimecrolimus |
0187-5102 | ELIDEL | Pimecrolimus |
0187-5103 | ELIDEL | Pimecrolimus |